Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian E. Krop(Yale Cancer Center), Patricia LoRusso(Yale Cancer Center)
Cited by 314
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
|Nature|2016|629
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409